Welcome to our dedicated page for Argan SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. (NYSE: AGX) is a Delaware corporation whose common stock is listed on the New York Stock Exchange, and it files periodic and current reports with the U.S. Securities and Exchange Commission. This SEC filings page brings together Argan’s Forms 10-K and 10-Q, as well as its frequent Form 8-K current reports, which disclose material events such as financial results, major project contracts and dividend declarations.
In its Form 8-K filings, Argan reports items like quarterly earnings releases under results of operations and financial condition, regular quarterly cash dividend announcements, and significant EPC contract awards received by subsidiaries such as Gemma Power Systems and Atlantic Projects Company. These filings also confirm key corporate details, including Argan’s state of incorporation, the AGX trading symbol and its New York Stock Exchange listing.
For investors and analysts, Argan’s annual reports on Form 10-K and quarterly reports on Form 10-Q provide more comprehensive information on segment performance, project backlog, risk factors and accounting policies, while current reports on Form 8-K highlight specific developments between reporting periods. Filings may also describe how new EPC contracts, full notices to proceed and backlog additions affect the company’s future activity.
On this page, AI-powered tools summarize lengthy SEC documents, highlight the main points from Argan’s 10-K and 10-Q filings, and explain the significance of individual 8-K items, such as dividend changes or large contract awards. Users can also review insider and executive-related filings like Form 4, along with proxy materials, to gain additional insight into Argan’s governance and equity activity.
Argan, Inc. insider William F. Griffin, Jr., a director and non-executive chairman, reported an internal trust-to-trust transfer of company stock. On December 1, 2025, he moved 5,000 shares of Argan common stock from the Griffin Family Trust to the William F. Griffin Jr. Revocable Trust at a stated price of $0. The filing states this resulted in no change in his overall beneficial ownership of Argan shares.
After the transaction, the Griffin Family Trust held 0 shares, while the William F. Griffin Jr. Revocable Trust held 140,976 shares indirectly for his benefit. An additional 11,650 shares were indirectly held through the Peach Pit Foundation, for which his wife serves as trustee. No derivative securities were reported.
Argan, Inc. announced that subsidiary Gemma Power Systems entered into an engineering, procurement and construction (EPC) contract and received a full notice to proceed for an approximately 860 MW natural gas‑fired power plant in the ERCOT market. The company stated the full contract value will be included in its project backlog for the quarter ended October 31, 2025.
This adds a large, multi‑year EPC project to Argan’s pipeline. While financial terms were not disclosed, including the full amount in backlog signals future revenue recognition tied to project milestones after the notice to proceed.
Argan, Inc. announced that subsidiary Gemma Power Systems received full notice to proceed on an EPC contract for CPV’s Basin Ranch Energy Center in Ward County, Texas. The project is a 1,350 MW 2–1×1 combined-cycle power plant using GE 7HA.03 turbines, designed with an option to add carbon capture capability.
Construction is expected to begin this fall, with a scheduled completion in 2028. Argan stated that the full amount of the contract value will be included in its consolidated project backlog for the period ending October 31, 2025. This adds a sizable long-duration power project to Gemma’s pipeline, aligning with utility-scale gas generation and optional decarbonization features.
Argan Inc. (AGX) director Peter W. Getsinger reported open‑market sales of the company’s common stock. He sold 2,000 shares at $292 on October 17, 2025 and 6,493 shares at $294.39 on October 20, 2025.
Following these transactions, he directly holds 9,897 shares of Argan common stock. The filing identifies him as a Director and lists the transactions as open‑market sales reported on a Form 4.
Argan, Inc. (AGX) director Peter W. Getsinger reported insider transactions on Form 4. On October 15, 2025, he exercised an option to purchase 10,000 shares at $46.35 per share using a net settle method, resulting in 8,493 shares acquired. That same day, he gifted 333 shares to each of his three children, totaling 999 shares. On October 16, 2025, he transferred 1,000 shares to a donor advised fund managed by Martha's Vineyard Investment Advisors.
Following these transactions, his directly held position was 18,390 shares. The option was originally awarded on January 11, 2018, became exercisable on January 11, 2019, and has an expiration date of January 11, 2028.
Argan, Inc. (AGX) reported insider activity by an officer on 10/15/2025. The reporting person exercised stock options to acquire 5,235 shares at $42.31 and 4,765 shares at $33.81, then conducted an open‑market sale of 10,000 shares at an average price of $309.37.
Following these transactions, the filer reported 21,006 shares of common stock held directly. The reporting person is identified as Chief Executive Officer, Gemma.
AGX: A shareholder filed a Form 144 notice to sell 2,000 common shares, reflecting an aggregate market value of $584,000. The filing lists an approximate sale date of 10/17/2025 on the NYSE, with Morgan Stanley Smith Barney LLC as broker. Shares outstanding were 13,811,575.
The seller acquired 2,000 shares on 10/17/2025 via an option exercise under a registered plan paid in cash. Recent activity disclosed includes prior sales over the last three months: 1,000 shares on 09/19/2025 for $264,535.10 and 2,609 shares on 09/17/2025 for $625,325.12.
Argan, Inc. (AGX) insider activity: On October 13, 2025, a company officer exercised stock options and sold shares. The officer exercised 5,235 options at $43.10 and 4,765 options at $42.31, then sold 10,000 shares on the open market at an average price of $292.09. Following these transactions, the officer directly owned 21,006 common shares.
The reporting person is identified as an Officer (Chief Executive Officer, Gemma). The filing notes the transactions and resulting holdings, providing transparency into recent insider equity movements.
Argan Inc. (AGX): Director ownership change
Director James W. Quinn reported an internal transfer of 5,578 shares of Argan common stock on 10/10/2025, coded J, at a price of $0. The shares moved from the James W. Quinn 2025 GRAT No. 1 (indirect) to his direct ownership, which the report explains is a change in the form of beneficial ownership and not a sale.
Following the transactions, the filing shows 43,992 shares held indirectly via the GRAT and 5,578 shares held directly.
Director and CEO David H. Watson reported multiple stock transactions on 10/09/2025. He sold 4,441 shares on the open market at an average price of $277.01 per share and gifted 559 shares to the David and Laura Watson Foundation (a donor-advised fund). The Foundation then sold the 559 shares at $272.27 per share. After these reported transactions the filing shows the Reporting Person beneficially owned 47,132 shares directly.